Exicure, Inc. (XCUR) Revenue History
Annual and quarterly revenue from 2015 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
XCUR Revenue Growth
XCUR Revenue Analysis (2015–2024)
As of May 8, 2026, Exicure, Inc. (XCUR) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q3 2025) recorded $0 in revenue.
Looking at the longer-term picture, XCUR's 5-year compound annual growth rate (CAGR) stands at -17.3%, indicating revenue contraction over this period. The company achieved its highest annual revenue of $28.8 million in 2022.
When compared to Healthcare sector peers including SRPT (-2.2% YoY), ARWR (+14.1% YoY), and NTLA (+16.9% YoY). Compare XCUR vs SRPT →
XCUR Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| XCURCurrent | $0 | - | -17.3% | -2446.4% | |
 SRPT | $2.2B | -2.2% | +32.4% | -29.9% | |
 ARWR | $829M | +14.1% | +56.6% | 11.9% | |
 NTLA | $68M | +16.9% | +3.1% | -651.7% | |
 BEAM | $140M | +108.0% | +466.3% | -274.6% |
XCUR Historical Revenue Data (2015–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $500K | - | $500K | 100.0% | $-12,232,000 | -2446.4% |
| 2023 | $0 | -100.0% | $-1,423,000 | - | $-14,996,000 | - |
| 2022 | $28.8M | +6068.1% | $27.0M | 93.6% | $-1,831,000 | -6.4% |
| 2021 | $-483,000 | -102.9% | $-483,000 | 100.0% | $-62,549,000 | 12950.1% |
| 2020 | $16.6M | +1181.9% | $-15,481,000 | -93.2% | $-25,436,000 | -153.1% |
| 2019 | $1.3M | +998.3% | $1.3M | 100.0% | $-26,617,000 | -2053.8% |
| 2018 | $118K | -98.8% | $-14,001,000 | -11865.3% | $-21,819,000 | -18490.7% |
| 2017 | $9.7M | +838.1% | $-3,361,000 | -34.6% | $-10,407,000 | -107.1% |
| 2016 | $1.0M | -56.6% | $-12,623,000 | -1218.4% | $-16,162,000 | -1560.0% |
| 2015 | $2.4M | - | $-7,736,000 | -324.0% | $-13,144,000 | -550.4% |
See XCUR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs XCUR Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare XCUR vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonXCUR — Frequently Asked Questions
Quick answers to the most common questions about buying XCUR stock.
Is XCUR's revenue growth accelerating or slowing?
XCUR TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: -17.3%.
What is XCUR's long-term revenue growth rate?
Exicure, Inc.'s 5-year revenue CAGR of -17.3% reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is XCUR's revenue distributed by segment?
XCUR reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2015-2024 are available for download. Segment mix reveals concentration and diversification trends.